文献速递头颈部肿瘤放疗放疗物理与技术

头颈鳞癌放射敏感性综合分析

Comprehensive analysis of radiosensitivity in head and neck squamous cell carcinoma.
PubMed 文献 · Radiother Oncol · 2021-03-26

该研究整合单细胞测序、批量组织测序与去卷积数据,在细胞、患者和细胞类型层面分析头颈鳞状细胞癌(HNSCC)的放射敏感性;发现放射敏感性聚类与分子分型高度一致,非典型亚型癌细胞比经典型和基底型更敏感;并构建了放射抵抗评分,提示放射抵抗肿瘤中癌症-免疫相互作用增强。

要点

  • HNSCC癌细胞放射敏感性聚类与分子分型高度一致。
  • 非典型亚型癌细胞对放射的敏感性高于经典型和基底型。
  • 放射抵抗肿瘤中PD1-PDL1/PDL2与TIM3-Galectin9通路相互作用增强。

核心结论

  • HNSCC癌细胞放射敏感性聚类与分子分型高度一致,非典型亚型癌细胞比经典型和基底型更敏感。
  • 经典型和基底型共有的放射抵抗基因模块主要与细胞分裂和细胞周期调控相关。
  • 研究构建了放射抵抗评分,并识别出可能从放疗联合免疫检查点阻断中获益的HNSCC群体。

研究设计与样本

  • 研究分析既往研究中的1388个原发癌细胞单细胞转录组。
  • 研究使用TCGA HNSCC数据集,包含499个原发HNSCC样本的RNA-seq数据、DNA甲基化数据和临床信息。
  • 研究整合单细胞测序数据、批量组织测序数据和去卷积数据,在细胞、患者和细胞类型层面分析放射敏感性。

主要发现

  • 经典型和基底型共有的放射抵抗基因模块主要与细胞分裂和细胞周期调控相关。
  • 经典型特异性放射抵抗模块主要与代谢通路相关。
  • 基底型放射抵抗亚型特异性模块包括两个上皮分化相关模块和一个主要与内质网、凋亡及黏着斑相关的模块。
  • 放射抵抗肿瘤中PD1-PDL1/PDL2和TIM3-Galectin9通路的癌症-免疫相互作用增强,倍数变化分别为2.88(PD1)、1.44(PDL1)、3.22(PDL2)、1.47(TIM3)、1.88(Galectin9),FDR<0.001。
  • 放射抵抗肿瘤中缺氧反应、p53通路、NF-kappa-B通路和炎症反应相关转录活性异常激活(FDR<0.05)。

关键数值与推荐

  • 放射抵抗肿瘤中PD1、PDL1、PDL2、TIM3、Galectin9的倍数变化分别为2.88、1.44、3.22、1.47、1.88,FDR<0.001。
  • 放射抵抗肿瘤中缺氧反应、p53通路、NF-kappa-B通路和炎症反应相关转录活性异常激活,FDR<0.05。

临床怎么用

  • 研究提示放射抵抗评分可能用于识别可能从放疗联合免疫检查点阻断中获益的HNSCC患者。
  • PD1-PDL1/PDL2和TIM3-Galectin9通路及缺氧反应、p53、NF-kappa-B、炎症反应相关通路为放射抵抗HNSCC提供潜在治疗靶点。

局限性

  • 单细胞转录组分析基于既往研究的1388个原发癌细胞,样本来源有限。
  • 批量组织分析基于TCGA HNSCC数据集,为回顾性数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Radioresistance is a major barrier to the successful treatment of head and neck squamous cell carcinoma (HNSCC). METHODS: We took advantage of different types of data, including single-cell sequencing data, bulk tissue sequencing data and deconvolution data, to conduct a comprehensive analysis of HNSCC radiosensitivity at the cellular, patient, and cell type levels. Single-cell transcriptomes for 1388 primary cancer cells from a previous study were analysed. The TCGA HNSCC dataset including 499 primary HNSCC samples with RNA-seq data, DNA methylation data and clinical information were used for bulk tissue sequencing analyses and deconvolution. RESULTS: We found that radiosensitivity clustering of HNSCC cells was highly consistent with molecular typing, where cancer cells of the atypical subtype exhibited a higher sensitivity than those of the classical and basal subtypes. The common radioresistant gene modules of the classical and basal subtypes were mainly associated with cell division and cell cycle regulation; the classical subtype specific radioresistant module was mainly associated with metabolic pathways; and the basal radioresistant subtype specific modules included two epithelial differentiation-related modules and a module mainly associated with endoplasmic reticulum, apoptosis and focal adhesion. We developed a radioresistance score using genes that affect both the cancer cell response to radiation and the patient response to radiotherapy. An enhanced cancer-immune interaction through the PD1-PDL1/PDL2 and TIM3-Galectin9 pathways was observed in radioresistant tumours, with foldchange = 2.88 (PD1), 1.44 (PDL1), 3.22 (PDL2), 1.47 (TIM3), 1.88 (Galectin9) respectively and FDR < 0.001. Transcriptional activities related to the hypoxia response, p53 pathway, NF-kappa-B pathway and inflammatory response were abnormally activated in the radioresistant tumours (FDR < 0.05). CONCLUSIONS: This study comprehensively discussed the radioresistance of HNSCC, identified a group of HNSCCs that were likely to benefit from combined radiotherapy and immune checkpoint blockade, and proposed new targets for the treatment of radioresistant HNSCC.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Li G, Jiang Y, Li G, et al. Comprehensive analysis of radiosensitivity in head and neck squamous cell carcinoma. Radiother Oncol. 2021. PMID: 33775714. doi:10.1016/j.radonc.2021.03.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。